Bodenheimer T, Wagner EH, Grumbach K Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002 Oct 16;288(15):1909-14.
Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. J Am Geriatr Soc. 2005 May;53(5):871-4.
Charlson ME, Pompei P, Ales KL, MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
Chomutare T, Fernandez-Luque L, Arsand E, Hartvigsen G Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res. 2011 Sep 22;13(3):e65. doi: 10.2196/jmir.1874. Review.
Courtney KL, Demiris G, Rantz M, Skubic M Needing smart home technologies: the perspectives of older adults in continuing care retirement communities. Inform Prim Care. 2008;16(3):195-201.
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.
Goldstein DJ Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992 Jun;16(6):397-415. Review.
Hall AK, Stellefson M, Bernhardt JM Healthy Aging 2.0: the potential of new media and technology. Prev Chronic Dis. 2012;9:E67. Epub 2012 Mar 8.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
Hayes DK, Denny CH, Keenan NL, Croft JB, Sundaram AA, Greenlund KJ Racial/Ethnic and socioeconomic differences in multiple risk factors for heart disease and stroke in women: behavioral risk factor surveillance system, 2003. J Womens Health (Larchmt). 2006 Nov;15(9):1000-8.
Heil DP Predicting activity energy expenditure using the Actical activity monitor. Res Q Exerc Sport. 2006 Mar;77(1):64-80.
Hertzog MA Considerations in determining sample size for pilot studies. Res Nurs Health. 2008 Apr;31(2):180-91. doi: 10.1002/nur.20247. Review.
Jaja C, Pares-Avila J, Wolpin S, Berry D Usability evaluation of the interactive Personal Patient Profile-Prostate decision support system with African American men. J Natl Med Assoc. 2010 Apr;102(4):290-7.
Kyung Rim Shin, Mi Young Kim, Seung Eun Chung Methods and strategies utilized in published qualitative research. Qual Health Res. 2009 Jun;19(6):850-8. doi: 10.1177/1049732309335857.
Lin JS, O'Connor E, Whitlock EP, Beil TL Behavioral counseling to promote physical activity and a healthful diet to prevent cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2010 Dec 7;153(11):736-50. doi: 10.7326/0003-4819-153-11-201012070-00007. Review.
Maruthur NM, Wang NY, Appel LJ Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation. 2009 Apr 21;119(15):2026-31. doi: 10.1161/CIRCULATIONAHA.108.809491. Epub 2009 Apr 6.
Nam S, Han HR, Song HJ, Song Y, Kim KB, Kim MT Utility of a point-of-care device in recruiting ethnic minorities for diabetes research with community partners. J Health Care Poor Underserved. 2011 Nov;22(4):1253-63. doi: 10.1353/hpu.2011.0117.
Osborn CY, Egede LE Validation of an Information-Motivation-Behavioral Skills model of diabetes self-care (IMB-DSC). Patient Educ Couns. 2010 Apr;79(1):49-54. doi: 10.1016/j.pec.2009.07.016. Epub 2009 Aug 21.
Panz VR, Raal FJ, Paiker J, Immelman R, Miles H Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids. Cardiovasc J S Afr. 2005 Mar-Apr;16(2):112-7.
Parker C, Philp I Screening for cognitive impairment among older people in black and minority ethnic groups. Age Ageing. 2004 Sep;33(5):447-52. Epub 2004 Jun 24.
Schakel SF Maintaining a nutrient database in a changing marketplace: Keeping pace with changing food products-- A research perspective. Journal of Food Composition and Analysis 2001;14:315-322.
Schneider KM, O'Donnell BE, Dean D Prevalence of multiple chronic conditions in the United States' Medicare population. Health Qual Life Outcomes. 2009 Sep 8;7:82. doi: 10.1186/1477-7525-7-82.
Shemesh T, Rowley KG, Shephard M, Piers LS, O'Dea K Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta. 2006 May;367(1-2):69-76. Epub 2006 Jan 4.
Tothill P, James Hannan W Dual-energy X-ray absorptiometry measurements of fat and lean masses in subjects with eating disorders. Int J Obes Relat Metab Disord. 2004 Jul;28(7):912-9.
Webb TL, Joseph J, Yardley L, Michie S Using the internet to promote health behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy. J Med Internet Res. 2010 Feb 17;12(1):e4. doi: 10.2196/jmir.1376. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.